Traws Pharma, Inc. · NASDAQ:TRAW
Squadron Capital Management LLC reported a 6.00% stake in Traws Pharma, Inc. (Schedule 13G)
Event Sep 12, 2025 · Filed Sep 19, 2025
Squadron Capital Management LLC reported a 6.00% stake in Traws Pharma, Inc., 420,501 shares, as a passive investor on Sep 12, 2025. Filed Sep 19, 2025 (Schedule 13G).
- Stake
- 6.00%
- Shares
- 420,501
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Squadron Master Fund LP | 5.30% | 372,374 |
| Squadron Capital Management LLC | 6.00% | 420,501 |
| Matthew Sesterhenn | 6.00% | 420,501 |
| William Blank | 6.00% | 420,501 |
Source
Related
- Traws Pharma, Inc.
- Squadron Capital Management LLC
- Traws Pharma, Inc. shareholders
- Schedule 13G/A · Squadron Capital Management LLC · Aug 14, 2026
- Schedule 13G/A · Squadron Capital Management LLC · May 15, 2026
- Schedule 13G/A · Squadron Capital Management LLC · Feb 17, 2026
- Schedule 13G/A · Squadron Capital Management LLC · Nov 14, 2025
- Schedule 13G · Sirenia Capital Management LP · Aug 14, 2026
- Schedule 13G/A · Ikarian Capital, LLC · Aug 14, 2026
- Schedule 13G/A · Adage Capital Management, L.P. · Aug 12, 2026
- Schedule 13G/A · Perceptive Advisors LLC · May 15, 2026
- Schedule 13D/A · Orbimed Advisors LLC · May 5, 2026